Back to UTHR Stock Lookup
Pages: 1 2 »» Last Page

UTHR Related Analyst Ratings

May 15, 2013 12:40 PM Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold
Apr 26, 2013 08:58 AM Ladenburg Thalmann Downgrades United Therapeutics Corp. (UTHR) to Neutral
Feb 26, 2013 01:10 PM Brean Downgrades United Therapeutics (UTHR) to Hold, Says Price Target Acheived
Feb 4, 2013 10:18 AM Standpoint Research Upgrades United Therapeutics Corp. (UTHR) to Buy
Jan 23, 2013 08:36 AM Guggenheim Starts United Therapeutics Corp. (UTHR) at Neutral
Dec 13, 2012 07:58 AM Goldman Sachs Downgrades United Therapeutics Corp. (UTHR) to Sell
Oct 24, 2012 06:49 AM JPMorgan Downgrades United Therapeutics Corp. (UTHR) to Underweight
Oct 24, 2012 06:48 AM BMO Capital Downgrades United Therapeutics Corp. (UTHR) to Market Perform
Aug 3, 2012 03:03 PM Standpoint Research Downgrades United Therapeutics Corp. (UTHR) to Hold
Jul 27, 2012 02:54 PM Canaccord Genuity Maintains a 'Hold' on United Therapeutics (UTHR); Increasing FY12 Adcirca and Tyvaso Revenues
Apr 27, 2012 11:20 AM UPDATE - Canaccord Genuity Downgraded United Therapeutics (UTHR) to Hold; Sidelined on Uncertainty
Apr 27, 2012 07:52 AM Canaccord Genuity Downgrades United Therapeutics Corp. (UTHR) to Hold
Apr 20, 2012 10:05 AM Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect
Apr 12, 2012 07:43 AM Leerink Swann Downgrades United Therapeutics Corp. (UTHR) to Market Perform; Generic Risk
Mar 26, 2012 09:00 AM Canaccord Genuity Starts United Therapeutics Corp. (UTHR) at Buy
Mar 12, 2012 10:18 AM Standpoint Research Starts United Therapeutics Corp. (UTHR) at Buy
Feb 15, 2012 10:51 AM Auriga Maintains a 'Hold' on United Therapeutics (UTHR); Q4 Review
Feb 7, 2012 10:38 AM United Therapeutics (UTHR) Lower As Analyst Highlights Sandoz Generic Remodulin Filing
Dec 28, 2011 07:42 AM Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Sep 15, 2011 07:22 AM Goldman Sachs Downgrades United Therapeutics Corp. (UTHR) to Neutral
Sep 15, 2011 07:18 AM Goldman Sachs Upgrades Onyx Pharmaceuticals (ONXX) to Buy
Sep 7, 2011 05:54 PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform
Aug 25, 2011 09:52 AM Maxim Group Downgrades United Therapeutics Corp. (UTHR) to Hold
Aug 25, 2011 08:43 AM Goldman Sachs Cuts Price Target on United Therapeutics (UTHR), But Still Sees 30% Upside
Aug 25, 2011 07:36 AM Citi Downgrades United Therapeutics Corp. (UTHR) to Hold
Aug 25, 2011 07:04 AM Auriga Downgrades United Therapeutics Corp. (UTHR) to Hold; FREEDOM-C2 Fails To Hit Primary Endpoint
Aug 24, 2011 01:56 PM Citi Cuts United Therapeutics Corp. (UTHR) to Hold
Aug 24, 2011 09:28 AM JPMorgan Downgrades United Therapeutics Corp. (UTHR) to Neutral
Aug 24, 2011 07:12 AM Deutsche Bank Downgrades United Therapeutics Corp. (UTHR) to Hold; Oral Approval Likelihood Lowered
Aug 2, 2011 08:46 AM Goldman Sachs Sees Heavy Upside in United Therapeutics (UTHR) With Limited Risk
Jul 28, 2011 04:28 PM Citadel Securities Maintains a 'Neutral' on United Therapeutics (UTHR); Tyvaso Growth Returns, but We Remain Cautious Ahead of FREEDOM-C2 Data
Jun 20, 2011 07:35 AM Needham & Company Maintains a 'Buy' on Pluristem Therapeutics (PSTI); Enters into Early-Stage Licensing Agreement Around PLX Cells
Jun 13, 2011 09:53 AM RBC Capital Downgrades United Therapeutics Corp. (UTHR) to Sector Perform
Jun 7, 2011 07:54 AM Citadel Securities Downgrades United Therapeutics Corp. (UTHR) to Neutral
May 20, 2011 07:23 AM Citadel Securities Upgrades United Therapeutics Corp. (UTHR) to Add on Statistical, pK Analysis of FREEDOM-M
Apr 29, 2011 07:09 AM Auriga Starts United Therapeutics Corp. (UTHR) at Buy
Apr 28, 2011 02:39 PM UPDATE: Wedbush Upgrades United Therapeutics (UTHR) to Outperform, Raises Fair Value Estimate to $94
Apr 28, 2011 12:35 PM United Therapeutics (UTHR) Shares Edge Higher as Wedbush Upgrades to Outperform
Apr 6, 2011 05:30 PM Citadel Securities Starts United Therapeutics Corp. (UTHR) at Neutral, Anticipating FREEDOM-M Outcome
Mar 25, 2011 07:10 AM Deutsche Bank Starts United Therapeutics Corp. (UTHR) at Buy; Attractive Risk/Reward into FREEDOM M
Feb 23, 2011 07:10 AM Stifel Nicolaus Starts United Therapeutics Corp. (UTHR) at Buy
Feb 8, 2011 06:59 AM Goldman Sachs Starts United Therapeutics Corp. (UTHR) at Buy, Sees 25% Upside
Dec 7, 2010 08:20 AM Credit Suisse Initiates Coverage on HGSI, EXAM, UTHR, BIIB, CELG, GILD, AMGN, LH
Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)
Jul 7, 2010 12:42 PM Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)
Jun 10, 2010 08:05 AM J.P. Morgan Upgrades United Therapeutics (UTHR) to Overweight
Apr 19, 2010 10:47 AM Auriga Maintains Positive Stance On United Therapeutics (UTHR) Citing Strong Tyvaso Uptake
Apr 5, 2010 08:39 AM Summer Street Upgrades United Therapeutics (UTHR) to Buy; Evidence of Continued Strong Tyvaso Rollout
Jan 13, 2010 11:41 AM Auriga Maintains a 'Buy' on United Therapeutics (UTHR); Named as Best 2010 Biotechnology Idea
Dec 17, 2009 10:57 AM Wedbush Maintains a 'Neutral' on United Therapeutics (UTHR); Raises PT & Estimates
Pages: 1 2 »» Last Page

Back to UTHR Stock Lookup